NCT02213016

Brief Summary

The purpose of this study is to evaluate clinical efficacy (affective and cognitive) in patients with moderate depression between TMS over the left Dorsolateral Prefrontal Cortex (DLPFC) with simulated TMS, as well as clinical response when 5 sessions / week are applied vs. 2 sessions / week. All patients will receive 15 TMS sessions as initial treatment (active or sham) and respondents will participate in an TMS follow-up on the left DLPFC for three months.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
80

participants targeted

Target at P25-P50 for phase_4

Timeline
Completed

Started Sep 2013

Longer than P75 for phase_4

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2013

Completed
11 months until next milestone

First Submitted

Initial submission to the registry

August 7, 2014

Completed
4 days until next milestone

First Posted

Study publicly available on registry

August 11, 2014

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2016

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2017

Completed
Last Updated

August 11, 2014

Status Verified

August 1, 2014

Enrollment Period

3 years

First QC Date

August 7, 2014

Last Update Submit

August 8, 2014

Conditions

Keywords

Stimulation magnetic transcranial, major depression, cognitive impairment

Outcome Measures

Primary Outcomes (1)

  • Total scores on the Hamilton depression scale depression

    After 15 sessions of treatment and at 3 months follow up

Secondary Outcomes (1)

  • Performance on the Wisconsin card sorting test

    After 15 sessions of treatment and at 3 months follow-up

Other Outcomes (1)

  • Performance on stop signal task

    After 15 sessions of treatment and at 3 months follow-up

Study Arms (4)

Transcranial magnetic stimulation

SHAM COMPARATOR

Sham repetitive Transcranial magnetic stimulation, 5 Hz, 5 sessions per week for three weeks: Total of 15 sessions.

Device: Sham Transcranial Magnetic Stimulation

Transcraneal magnetic stimulation

ACTIVE COMPARATOR

Active repetitive Transcranial magnetic stimulation, 5 Hz, 5 sessions per week for three weeks: Total of 15 sessions.

Device: Transcranial Magnetic Stimulation

Sham Comparator

SHAM COMPARATOR

Sham repetitive Transcranial magnetic stimulation, 5 Hz, 2 sessions per week for 7 1/2 weeks: Total of 15 sessions.

Device: Sham Transcranial Magnetic Stimulation

Active Comparator

ACTIVE COMPARATOR

Active repetitive Transcranial magnetic stimulation, 5 Hz, 2 sessions per week for 7 1/2 weeks: Total of 15 sessions.

Device: Transcranial Magnetic Stimulation

Interventions

Also known as: TMS device MagVenture model MagPro 100
Active ComparatorTranscraneal magnetic stimulation
Also known as: TMS device Magventure, model MagPro 100. COIL COOL-B65.
Sham ComparatorTranscranial magnetic stimulation

Eligibility Criteria

Age18 Years - 35 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Clinical diagnosis of major depressive disorder
  • Having a greater or equal score to 18 points in the Ham-D scale at the moment of the initial evaluation
  • Treatment free patients

You may not qualify if:

  • Epilepsy or seizure risk record
  • Carry metallic objects in the head (such as arterial clips, plates, screws), eye or brain

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Psychiatry and Mental Health, Faculty of Medicine, UNAM

Mexico City, Mexico City, 04510, Mexico

RECRUITING

Related Publications (2)

  • Unable to connect to PubMed to validate , last attempt on May 29, 2014 at 3:25 PM EDT

    BACKGROUND
  • Armas-Castaneda G, Ricardo-Garcell J, Reyes JV, Heinze G, Salin RJ, Gonzalez JJ. Two rTMS sessions per week: a practical approach for treating major depressive disorder. Neuroreport. 2021 Dec 8;32(17):1364-1369. doi: 10.1097/WNR.0000000000001737. Epub 2021 Oct 28.

MeSH Terms

Conditions

Depressive Disorder, MajorCognitive Dysfunction

Interventions

Transcranial Magnetic Stimulation

Condition Hierarchy (Ancestors)

Depressive DisorderMood DisordersMental DisordersCognition DisordersNeurocognitive Disorders

Intervention Hierarchy (Ancestors)

Magnetic Field TherapyTherapeutics

Central Study Contacts

Gabriela Armas-Castañeda, MD

CONTACT

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Technical academic

Study Record Dates

First Submitted

August 7, 2014

First Posted

August 11, 2014

Study Start

September 1, 2013

Primary Completion

September 1, 2016

Study Completion

February 1, 2017

Last Updated

August 11, 2014

Record last verified: 2014-08

Locations